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Abstract
Background: We aim to study surgical technique and analyze the related factors affecting tumor total removal and
postoperative endocrinological remission for endoscopic endonasal pituitary adenomas surgery.
Methods: We retrospectively analyzed 178 endoscopic endonasal pituitary adenomas surgery from March 2011 to
May 2014. Endonasal approach included the routine transnasal-sphenoidal approach, transnasal- maxillary sinus
approach in four cases and transnasal-clivus approach in one case.
Results: According to postoperative imaging data and endocrine examination results, total removal was achieved
in 129 patients (72.5%), and endocrinological remission was achieved in 38 patients with functional adenomas (44.
1%). Statistical analysis of the clinical data showed that total removal rate was much closely related to tumor
volume (P = 0.006), and tumor invasiveness (P < 0.001).
Conclusions: In this study, we found tumor sizes and invasion of cavernous sinus were related to total removal rate
and endocrinological remission rate; the direction and degree of tumor invasion, and the surgeon’s experience
were the key influence factors of the endocrinological remission rate for invasive functional pituitary adenomas.
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Background
Trans-sphenoidal surgery for pituitary adenomas was
firstly invented by Herman Schloffer more than 100 years
ago [1]. It was then developed from trans-sphenoidal
surgery by microscope into endoscope-assisted micro-
scope, and nowadays has progressed to pure endoscopic
endonasal surgery [2, 3]. The purpose of this article is
to introduce the experience of endoscopic endonasal
surgery for pituitary adenomas by a group of two
neurosurgeons in recent 3 years, and how we improve
our surgical techniche through practice, at mean time
to discuss the pros and cons of the endoscope in this
approach.
Methods
1. Clinical materials: from March 2011 to May 2014,
178 endoscopic endonasal operations were
performed on patients with pituitary adenomas.
Among these, 78 cases were male patients and 100
cases were female patients, ranged from 14 to
74 years old (mean 46.1 years). The main clinical
features were: 65 cases with impairment of version
and visual field, 6 cases with ocular motility
disorders, 28 cases of menstrual disorder and
secondary amenorrhea(in prolactinomas, some GH-
secreting adenomas and plurihormonal adenomas),
six cases with galactorrhea, 25 cases with male sexual
dysfunction, 49 cases with acromegaly, 4 cases
with central obesity and hirsutism, one case with* Correspondence: endoscope_huashan@163.com
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developmental retardation, and 19 patients
underwent a reoperation for tumor recurrence.
2. Radiographic examination: Preoperative sellar
coronary CT and MR examinations were performed
in all patients. Modified Hardy classification was
utilized according to the size of tumor. 108 cases
(60.7%) were invasive adenomas and 70 cases
(39.3%) were non-invasive adenomas (Table 1). The
direction of tumor invasion: prolactinomas were
prone to invade laterally (72%,13/18);GH-secreting
adenomas were prone to invade inferiorly (45%,13/29);
Non-functional adenomas can invade in all directions.
3. Endocrinological Evaluation: All patients underwent
complete preoperative endocrinological evaluation:
four cases had abnormal elevation of plasma cortisol
and ACTH. three cases had abnormal elevation of
thyroid hormones, 49 cases had abnormal elevation
of GH and IGF-1, 16 cases had slight elevation of
PRL(<100 ng/mL), 30 cases had significant elevation
of PRL(>100 ng/mL).
4. Surgical methods: The instruments including 0°, 30°,
wide-angle lens, 4-mm diameter rigid endoscopes
(Karl Storz, Germany), endoscopic surgical instruments
(Karl Storz, Germany), IPC power system and
endoscope irrigation system(Medtronic, USA).
And Selectable Depth Doppler monitor system
(VTI, USA) was generally used.
All patients were treated by the same group of two
neurosurgeons (Dr. Yongfei Wang and Dr. Xuefei
Shou), without the help of ENT colleagues. Surgical
procedure: the right nostril was usually chosen as
the operation channel, unless the tumor obviously
invaded the right cavernous sinus or the right nostril
was too narrow to proceed. In the case that tumor
was large or bilateral cavernous sinuses were
invaded, both nostrils were used, and one or
bilateral middle turbinates were removed to gain
more operative space. After the sphenoid sinus was
opened, sellar dura was fully exposed according to
the size and location of the tumor (the routine
transnasal-sphenoidal approach). To expose the
tumor, if the posterior ethmoid sinus or anterior
skull base was invaded, the ipsilateral middle turbinate
would be removed (transnasal- ethmoid sinus
approach); if maxillary sinus or pteryogalatine fossae
was invaded, the ipsilateral middle turbinate and
uncinate process would be removed (transnasal-
maxillary sinus approach); if lower clivus or foramen
magnum was invaded, the middle and lower clivus
would be removed (transnasal-clivus approach). All
the microadenomas underwent extracapsular
dissection while macroadenomas were resected
piecemeally (intrasellar firstly, then suprasellar,
finally, explore the bilateral medial wall of cavernous
sinus and remove the residual tumor invading into
the cavernous sinus if possible). Repair the sellar
diaphragma intentionally if any defect was found.
5. Postoperative nosocomial evaluation and outpatient
follow-up: all the patients enrolled underwent a total
endocrine evaluation on the first postoperative day
and MRI scan within 3 days after the surgery. The
endocrine function was assessed in the 1 month,
3 months, 6 months and each year after discharge.
MRI scan was advised each time since the second
follow-up (the third postoperative month). The
criteria for endocrinological remission of GH-
secreting adenoma were: OGTT nadir GH level < 0.4
ug/L or random GH level < 1 ug/L and IGF-1 level
was at normal range according to the age and sex
simultaneously. The normal range for PRL was
<22.80 ug/L for male, and <30.74 ug/L for female.
6. Learning curve: we separate the 178 cases into stage
one (89 cases) and stage two (89 cases), which was
treated 18 months formerly and 20 months later,
respectively.
7. Statistical Evaluation: chi-square test, Fisher’s exact
test and Logistic regression analysis were used. A
p value < 0.05 was considered significant. Statistical
analyses were performed using SPSS software
(version 17.0 for Macintosh).
Results
This study included nonfunctioning adenomas in 92 cases,
prolactinomas in 32 cases, GH-secreting adenomas in 43
Table 1 General material
PRL GH ACTH Pluri + TSH Nonfunctional Total
Number 32 43 4 7 92 178
Gender
Male 13 20 0 3 42 78 (43.8%)
Female 19 23 4 4 50 100 (56.2%)
Invasiveness
Non 14 14 2 2 38 70 (39.3%)
Invasive* 18 29 2 5 54 108 (60.7%)
Hardy Grade
I 6 6 2 0 3 17 (9.5%)
II 12 21 1 4 20 58 (32.6%)
III 11 14 0 2 45 72 (40.4%)
IV 3 2 1 1 24 31 (17.4%)
Removal rate
Total 25 31 3 4 66 129 (72.5%)
Near total 6 7 1 3 16 33 (18.5%)
Subtotal 1 5 0 0 10 16 (9.0%)
Invasive*: pituitary adenomas with suprasellar or parasellar or infrasellar extension
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cases, plurihormonal adenomas in seven cases and
ACTH-secreting adenomas in four cases. All the diagno-
ses were based on pathological, immunohistochemical
and clinical evaluation.
Among the 178 cases, besides the routine transnasal-
sphenoidal approach, the transnasal- maxillary sinus
approach was in four cases, and the transnasal-clivus
approach was in one case. According to postoperative
imaging data, total removal was achieved in 129 patients,
near total removal was in 33 and subtotal removal was
in 16. Endocrinological remission was achieved in 38
patients with functional adenomas (44.1%) (Table 1).
In this study, 15 cases in Knosp 1 or 2 growing lat-
erally without cavernous sinus invasion were easier to
reach total removal (80%). In 29 cases in Knosp 3, defect
can easily be found in medial wall of cavernous sinus
under endoscopy. Tumor invading into the cavernous
sinus can be removed under direct vision or open the
medial wall of cavernous sinus under Doppler monitor-
ing (total removal in 17 cases). In 28 cases in Knosp 4,
tumor had involved cavernous sinus and internal carotid
artery (ICA), even the lateral wall of cavernous sinus,
and cannot be totally removed. Among these cases, 19
soft tumors can be aspirated carefully around ICA to
reach near total removal (Figs. 1 and 2) while we
withdrew the continued resection in 9 tough tumors.
Most of invasive macroadenomas were difficult to be
totally removed. However, 29 cases of macroadenomas
in Hardy stage III-IV grew expansively, and the direct
endoscopic vision and the integrity of tumor capsule
make them easily to be removed totally even they
were tough (Fig. 3). Further analysis shows that the
tumors invading laterally (cavernous sinus etc.) are
harder to be removed than those invading vertically
(suprasellar, sphenoid sinus, clivus etc.) (P = 0.003)
(Table 2). Univariate analysis of the clinical data
showed that total removal rate was related to tumor
volume (P = 0.006), reoperation (P = 0.011), learning
curve (P = 0.009) and much closer to tumor invasive-
ness (P < 0.001) (Table 3).
Eighty-six cases in this study (48%) are functional pitu-
itary adenomas. Thirteen prolactinomas in this study
invaded cavernous sinus, among which five cases got
postoperative imaging total removal, but only three cases
meet the remission standard. GH-secreting adenoma
can severely affect multiple organic functions. We
recommend acromegaly patients taking somatostatin
analogue firstly to relieve systemic symptoms and reduce
the risk of general anesthesia [4]. In this study, 24 acro-
megaly patients took long-acting somatostatin analogue
for 3 to 6 months preoperatively, which caused the
shrinkage of tumor and notable reduce of GH and IGF-1
levels while tumor invasiveness showed no change.
Among these patients, tumors were relatively tough and
capsules were more obvious, which made tumor easier
to be removed totally.
Serious postoperative complications were four cases of
intracranial infection, one case of intracranial hemorrhage,
and one case die of hydrocephalus.
Intracranial hemorrhage is one of the most serious
complications of endoscopic endonasal surgery for two
reasons: 1) Residual tumor bleeding, if together with
sellar diaphragm rupture, can penetrate to the subarach-
noid space or ventricles. 2) The excessive collapse of
sellar diaphragm may rupture the artery perforators
which adhere to the sellar diaphragm and cause acute
bleeding. The former bleeds slowly and can be con-
firmed by postoperative CT scan. The latter may cause
massive hemorrhage and progresses quickly, even lead
to death intraoperatively, which makes it hard to handle
with. One case had acute intracranial bleeding. In this
case, tumor with atypical apoplexy was removed
smoothly. When the sellar diaphragm collapsed to sellar
floor quickly, diaphragm became bulged and cyan in a
sudden. We cut open the diaphragm immediately and
proved suprasellar arterial hemorrhage, but the bleeding
vessel was not under direct view. A modified pterional
approach was done in no time with autologous blood
transfusion and volume supplement. At last, the broken
artery was clipped and confirmed a branch of right
Fig. 1 a Preoperative MRI shows left cavernous sinus invasion, encasing
left internal carotid artery. b Postoperative MRI shows the tumor
invading into cavernous sinus was mostly excised
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anterior cerebral artery attached to the sellar diaphragm.
The patient was recovered well and discharged 10 days
later. Through this case, we suggest that excessive sellar
diaphragm collapse should be prevent, or reduce the
pressure by a positive opening the diaphragm and re-
lease of cerebrospinal fluid.
Forty-eight patients (27%) had intraoperative cerebro-
spinal fluid leakage, which is closely related to tumor
size (P < 0.001) other than texture (P = 0.378). One of
the reasons may be the sellar diaphragm would be
compressed and weakened by large tumors. The proper
use of repair technology can ensure the successful repair.
Forty-seven cases (98%) in this study repaired success-
fully at the first time, which means no recurrence at the
long-time follow up. One cerebrospinal rhinorrhea
occured at the 10th postoperative day, and was cured
with another transsphenoidal repair. The possible reason
of failure may be that mucosal flap is too small to cover
the skull base. For the defect over 5 mm in diameter or
multiple defects, we recommend the multilayer repair
Fig. 2 a The sellar floor was open to expose the tumor. b The tumor invading left cavernous sinus was removed. *marks the defect of the medial
wall of cavernous sinus. c Cavernous ICA is localized by intraoperative Doppler ultrasound. d No residue tumor was observed under endoscopy
Fig. 3 a preoperative MRI shows giant pituitary adenoma, growing expansively. b postoperative MRI shows tumor was totally removed
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technology: we use Absorbable Hemostat (Surgicel,
USA) for the first layer to protect the arachnoid and the
absorbable artificial dura (DuroGen, USA) for the sec-
ond to set inside dura; autologous fat, fixed by gelatin
sponge, is used to fulfill the dura defect on the third
layer. The fourth layer is the pedicled nasal septal muco-
sal flap to cover the skull base and sealed by biological
glue (Fibrin Sealant, China). All these multilayers should
be propped by tela iodoformum for 2 weeks. And post-
operative lumbar continuous drainage is advised within
5 days. All the skull base reconstruction materials are
absorbable or autogenous. Non-absorbable material
should be avoided. Four postoperative intracranial infec-
tions may be caused by early incomplete nasal disinfec-
tion, intra- or postoperative cerebrospinal leak. Further
disinfecting the nasal cavity and paranasal sinus with
Anerdian and hydrogen peroxide repeatedly, repairing
the cerebrospinal leakage reasonably can prevent the in-
fection effectively. One elder patient died of the second-
ary pneumonia caused by postoperative hydrocephalus.
During the follow-up, five patients with residual non-
functioning adenomas and 12 patients with residual GH-
secreting adenomas underwent stereotactic radiosurgery.
Discussion
Endoscopic endonasal surgery, which has unlimited po-
tential, provides a new choice for pituitary adenomas to
neurosurgeons undoubtedly. However, so far, most neu-
rosurgeons’ unfamiliar to the nasal skull base anatomy
or the endoscopic techniques limits the development of
this surgery. Other limits may be the lack of cooperation
with rhinologists, or the postoperative complications
such as cerebrospinal rhinorrhea, secondary intracranial
infection. Besides, the neurosurgeons, who are used to
the traditional microsurgery, believe that there is no dif-
ference in exposure and removal of intrasellar tumor be-
tween microscopes and endoscopes. And it cannot be
denied that, to the same experienced surgeon, duration
under microscope is less than endoscope [5]. Therefore,
development of this procedure requires neurosurgeons
to keep summarizing how to take the advantage and
avoid disadvantage.
Operative experience
To keep the surgical field clear, it is important to minimize
the nasal mucosa damage and mucosa bleeding. After the
sellar dura was opened, tumor should be removed in the
order: intrasellar firstly, then suprasellar, sellar diaphragm
next, the bilateral medial wall of cavernous sinus finally.
The adhesion of the suprasellar tumor to sellar diaphram
can be found in most cases, which requires careful separ-
ation. It is recommended that using a small piece of sponge
to protect sellar diaphragm while separate the tumor or
capsule, especially in corners. The last step is to check the
integrity of bilateral medial wall of cavernous sinus.
Micro-Doppler probe was used mainly in the cases
with cavernous sinus invasion. Tumors like this always
destroy sellar floor, clivus or other bone landmarks.
Compression and displacement of ICA cavernous seg-
ment are also common. Thus, the stretch caused by
scraping intracavernous tumor blindly may cause ICA or
its branch rupture, leading massive hemorrhage. Intra-
operative Doppler monitoring can recognize and secure
ICA and its branch noninvasively. To stop massive cav-
ernous sinus venous hemorrhage, patient’s head should
be lift to reduce the pressure of venous sinus, and one
suction tube should be put against the bleeding point.
Meanwhile the residual tumor should be keep removing
with curette or another suction tube.
Table 2 Analysis of total removal related factors
Number Total removal Non-total P value
Tumor size
HardyI,II 75 63 (84%) 12 (16%) 0.006
Hardy III,IV 103 66 (64%) 37 (36%)
Endocrine type
Functional 86 63 (73%) 23 (27%) 0.868
Non 92 66 (72%) 26 (28%)
Invasiveness
Invasive 109 61 (56%) 48 (44%) 0.0001
Non 69 68 (99%) 1 (1%)
Invading direction
Purely laterally 44 24 (55%) 20 (45%) 0.003
Purely vertically 37 32 (86%) 5 (14%)
Knosp Grade
Knosp 1–2 15 12 (80%) 3 (20%) 0.002
Knosp 3–4 57 18 (32%) 39 (68%)
Table 3 Logistic regression analyses identifying predictors of total removal in 178 patients with pituitary adenomas
Factor (category) Univariate analysis Multivariate analysis
OR p Value 95% CI OR p Value 95% CI
Volume 0.467 0.006 0.306–0.713 NS
Invasivenss 0.018 <0.001 0.002–0.134 0.029 0.001 0.004–0.224
Reoperation 0.407 0.011 0.204–0.81 NS
Learning curve 0.401 0.009 0.203–0.792 NS
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Analysis of total removal related factors
Once the tumor breaks through the capsule, grows inva-
sively and involves several anatomical spaces (e.g. sellar
diaphragm, cavernous sinus, ICA, dorsum sellae, clivus
etc.), total removal is seldom achieved. Moreover, the tu-
mors invading laterally are harder to be removed than
those invading vertically. One of the reasons may be that
the bone structure of sphenoid sinus or clivus can be re-
moved by micro-drill to expand the exposure to reach
total removal. It may be another reason that the macroa-
denomas, which adhere to sellar diaphragm or even
break through the diaphragm and compress the third
ventricle, can be removed totally by stripping the capsule
or open the diaphragm (Fig. 4) while cavernous sinus,
involving in lots of vessels and nerves, is hardly to gain
enough surgical exposure [6].
Analysis of endocrinological remission related factors for
functional pituitary adenomas
The main surgical goal for functional pituitary adenomas
is to achieve the endocrinological remission.
Although the first choice for prolactinomas is drug
therapy, we use the operative therapy for those who have
surgical indications (resistant to medical therapy, and in-
tolerable adverse medication effects) [7]. Why invasive
prolactinomas which got imaging total removal, could
not meet the remission endocrinological standard? We
speculate that it may be caused by: first, the medial wall
Fig. 4 a Preoperative MRI shows giant pituitary adenoma, with a dilation of 5.0 cm, compressing foramen of monro. b Postoperative MRI shows
the total resection of tumor
Fig. 5 a Preoperative MRI shows a GH pituitary macroadenoma of Knosp grade III. b Postoperative MRI shows total tumor resection. Endocrinal
evaluation on the third postoperative month shows: GH: 0.57 ng/ml, IGF-1: 207 ng/ml (normal range, 94 ~ 284 ng/ml)
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of cavernous sinus was infiltrated; second, the tumor
capsule was not removed totally. Based on these hypoth-
eses, in later time, we use endoscope to inspect carefully
and closely to the tumor cavity and do the biopsy for the
fast frozen sections if necessary.
To GH-secreting adenomas, just like invasive prolacti-
nomas, the same problem is that although the postoper-
ative imaging shows a total removal of the invasive
tumor, endocrinological remission was still not achieved.
Among 22 GH-secreting adenomas invading cavernous
sinus, 12 got the imaging total removal while only four
patients reached biochemical remission (Fig. 5).
Analysis of multiple logistic regression also proves the
point above: the endocrinological remission rate is re-
lated to tumor invasiveness only (P = 0.008) (Table 4).
Learning curve
At the beginning of endoscopic surgery, problems like
inadaptation to the endoscopic visualization, the narrow
operational space or lack of endoscopic instruments usu-
ally showed up. It takes patience and perseverance for
neurosurgeons to overcome difficulties, familiarize with
and adapt to the endoscopic surgery. Thus, it is recom-
mended to the beginners that operating on those who
have a smaller tumor and bigger nasal cavity at the very
start. Removal of partial middle turbinate to gain more
operational space is also a good choice. Of course, with
the company of an experienced ENT doctor, the nasal
part of the operation can be done more quickly and neu-
rosurgeons can be more confident. Our own experience
is: after accomplishing 30 to 40 endoscopic surgeries,
neurosurgeons are more skilled and good teamwork be-
tween operator and his assistant is easy to get. Then
some harder surgery like invasive pituitary tumor resec-
tion can be tried. Besides, we had gathered extraordinary
experience for transsphenoidal surgery under micro-
scope for a long time, which shortened our learning
curve extremely.
We separate 178 cases into two stages. The ratio of in-
vasive tumor is obviously increased (P = 0.009). This is
because with the gathering of experience, we realize the
specific advantage of invasive pituitary adenoma resec-
tion under endoscope and choose more invasive tumors
or macroadenomas in the latter stage intentionally,
which makes the total removal rate drop from 81 to 64%
(P = 0.009) unexpectedly. It’s comforting that the
remission rate in invasive functional adenomas rises ap-
parently (from 11 to 29%). Besides, because of a thor-
ough disinfection of surgical field, the proficient skill
and the improvement of reconstruction of skull base, se-
vere complications (including intracranial infection,
intracranial hemorrhage, and postoperative cerebro-
spinal rhinorrhea) never occurred in the latter stage
(Table 5). Compared with other reports [8–10], our im-
aging total removal rate is similar (72.5%), while endo-
crinological remission rate of functional pituitary
adenoma is relatively lower (44.2%). This may be caused
by the very strict endocrinological remission standard
and the much higher ratio of invasive adenomas (60.7%).
Conclusions
In conclusion, this study demonstrates that endoscopic
endonasal surgery for pituitary adenomas has a high im-
aging total removal rate (72.5%) while the endocrino-
logical remission rate of functional pituitary adenoma is
not that satisfied (44.2%), which means long-time follow
up, drug therapy or stereotactic radiotherapy is neces-
sary. The invasion of pituitary adenoma to cavernous
sinus is closely related to the surgical results. Due to
operator’s elevation of surgical skills and familiarity to
endoscopic surgery, tumor removal rate and endocrino-
logical remission rate is improved gradually, with the
decrease of the complication rate and the length of
learning curve.
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Table 4 Logistic regression analyses identifying predictors of
endocrine remission in 86 functional adenomas
Adenoma
characteristics
Univariate analysis Multivariate analysis
OR p Value 95% CI OR p Value 95% CI
Volume 0.310 0.005 0.161–0.597 NS
Invasiveness 0.137 <0.001 0.051–0.366 0.234 0.008 0.08–0.686
Table 5 Learning curve
First stage Second stage P value
Number of cases 89 89 1.000
Total removal 72 (81%) 57 (64%) 0.009
Invasive adenomas 45 (51%) 63 (71%) 0.009
Endocrine remission rate of
invasive functional adenomas
2/19 (11%) 10/35 (29%) 0.178
Severe complications* 5 1 0.211
Severe complications*: intracranial infection, intracranial hemorrhage, CSF
rhinorrhea and hydrocephalus which required a reoperation
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